Diagnosed in 2011 and proud to be a 10-year multiple myeloma survivor, Sheri Baker is currently on Revlimid and Darzalex Faspro therapy. Motivated by her desire to help other patients and caregivers, Sheri established the Treasure Valley Multiple Myeloma Support Group in Boise, Idaho in 2017. This is the third time that Sheri will be attending the ASH conference and she is very grateful to the IMF and their sponsors for the opportunity.  

Follow Sheri on Twitter:@blondie1746
Support Group Website: Treasure Valley Multiple Myeloma Support Group

 

 

Power Over Your Mind

Power Over Your Mind

“You have power over your mind – not outside events.  Realize this, and you will find your strength.”—Marcus Aurelius, Meditations As the 63rd annual meeting of the American Society of Hematology (ASH) wrapped up this week, I am looking to the future with hope and excitement. I admit my brain is a bit tired from trying to process all the technical data, but I am trying to have power over my mind! Since I have relapsed twice in my 10 years of living with multiple myeloma, I tend to be...

read more
From Technical Glitches to Relaxation

From Technical Glitches to Relaxation

“When you arise in the morning think of what a privilege it is to be alive, to think, to enjoy, to love…” —Marcus Aurelius, Meditations This year at the Annual Meeting of the American Society of Hematology (ASH), there have certainly been challenges with technology, whilst holding an in-person meeting and a virtual meeting at the same time.  There are presenters and moderators attending virtually from all over the world.  This can be stressful for those watching, as well as...

read more
And Away We Go!

And Away We Go!

The official start of the American Society of Hematology (ASH) annual meeting is Saturday, but Friday was filled with symposiums sponsored by various organizations. In my first year attending ASH, I had no idea what to expect from the symposium. Now, I look forward to them. The panel of doctors each presents a patient case and various options for treatment. Attendees are polled about which treatment they would choose. Then the presenter shares data about treatment options. At the end of the...

read more
Pre-ASH Blog: A Strange Year – Part 2

Pre-ASH Blog: A Strange Year – Part 2

I can’t believe we are still here.  And by here, I mean this:  holding our support group meetings virtually, having our Support Group Leader Summit (SGLS) virtually, and attending the 63rd American Society of Hematology (ASH) Annual Meeting virtually.  There is a saying, “the more things change, the more they stay the same.”    This year, ASH will be a combination of in-person and virtual.  It should be interesting to watch the presentations.  Maybe it...

read more